Impact Factor
3.99
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
5.32
1,143 total citations
h5-index
44
h5 depth signal
Cited share
83.5%
192 of 230
Total citations
1,143
Citation footprint
Metric signal
4.71
External metric anchor
Self-citation
6.6%
75 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United Kingdom
554
United States
348
Netherlands
230
Australia
178
Canada
131
Citing Fields of Research
Medical Ethics
642
Healthcare Policy
269
Economics
149
Oncology
115
Statistical Methods
59
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
4,174
Articles tracked across the journal lifetime
Indexed publication set
230
192 cited publications
Last 12 months
121
10.1 publications/month
Open access share
65.3%
79 OA publications in the last year
Leading citing country
United Kingdom
554 citing publications
Leading citing field
Medical Ethics
642 citing publications
Latest tracked publication
15 October 2026
10 recent records available
Coverage & Indexing History
v1, 1992-
v1, 1992-
Research Focus & Classification
Indexed Subjects
Medical Ethics
Healthcare Policy
Cardiology
Oncology
Economics
Broad Categories
Drug Therapy
Pharmacology
Medical Ethics
MeSH Descriptors
Drug Therapy
Pharmacology
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
02
DOI 10.1007/s40273-026-01668-3
Open DOI
Waiting for Trial Evidence or Using Real-World Evidence: Trade-Offs for Coverage with Evidence Development
03
04
05
DOI 10.1007/s40273-026-01663-8
Open DOI
Correction: Comparing User‑Written Codes for Performing Economic Evaluations in Stata
06
DOI 10.1007/s40273-026-01658-5
Open DOI
Justifying and Classifying Adults’ Roles in Child Health State Valuation: A Novel Taxonomy
07
08
DOI 10.1007/s40273-026-01665-6
Open DOI
Meta-Analysis of Incremental Net Benefit from Trial-Based Health Economic Evaluations in R: A Tutorial
09
DOI 10.1007/s40273-026-01670-9
Open DOI
Developing an Australian Value Set for the COCOON Carer Quality-of-Life Measure for Use in Economic Evaluations
10
DOI 10.1007/s40273-026-01652-x
Open DOI
Derivation and Validation of Charlson, Elixhauser and RxRisk Cost-Based Comorbidity Indices: A Register-Based Study of 350,000 Individuals Over 11 Years
Background Comorbidity indices are widely applied to adjust for confounding in observational research. However, health economic analyses often adjust for comorbidity using mortality-based indices, despite health conditions being likely a...
Bibliographical & Catalog Notes
Title from cover.
Supplements accompany some vols.
Also issued online.
Supplemented by: PharmacoResources, 1992-1995; by: PharmacoEconomics & outcomes news, 1996- .